Merriman Curhan Ford & Co. Equity Research on
Starpharma Holdings Ltd. (OTCQX: SPHRY)

Thank you for your interest in Merriman Curhan Ford & Co.’s U.S. equity research on Starpharma Holdings Ltd. (OTCQX: SPHRY). Please fill out and submit the electronic form below to immediately receive the research.

Merriman Curhan Ford & Co. initiated research coverage on Starpharma in June 2007, rating its American Depositary Receipts (OTCQX: SPHRY) as a buy. The U.S. based investment bank also acts as the company’s Investment Bank Principal American Liaison (PAL) on the International OTCQX listing service.

Already registered: click here

Please provide the following information to complete your registation.
An asterisk (*) indicates a required field.
*First Name:
*Last Name:
*E-mail Address:
*Phone Number:
*A Current Starpharma Investor:             

 




About OTCQX

Listed Companies
 
Companies that Should List
 


MCF & Co.’s OTCQX Clients
Day Software Holding AG
 
Starpharma Holdings Ltd.
 
Linc Energy, Ltd.
 


MCF & Co.’s OTCQX News
Recent News